Michael D. Moore
Impact in
-
- Immune cells in cancer
- Phagocytosis and Immune Regulation
-
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Inflammasome and immune disorders 1
- Single-cell and spatial transcriptomics 1
-
- Immune cells in cancer 3
- Co-authors
- William James (6 shared papers)Julian Buchrieser (2 shared papers)Sally A. Cowley (3 shared papers)Peter F. Renz (1 shared paper)Rowan Flynn (1 shared paper)Alexander Grundmann (1 shared paper)Bonnie van Wilgenburg (1 shared paper)Lee M. Jampol (3 shared papers)
- Journals
- American Journal of Ophthalmology (3 papers)Cell Death and Disease (1 paper)Experimental Hematology (1 paper)BMC Genomics (1 paper)Stem Cell Reports (1 paper)
- Partner nations
- United KingdomUnited StatesSpain
In The Last Decade
Michael D. Moore
9 papers receiving 401 citations
Peers
Comparison fields: 5 of 62
- Immunology 145
- Neurology 56
- Business and International Management 14
- Aging 11
- Virology 23
Countries citing papers authored by Michael D. Moore
This map shows the geographic impact of Michael D. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Moore more than expected).
Fields of papers citing papers by Michael D. Moore
This network shows the impact of papers produced by Michael D. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Moore. The network helps show where Michael D. Moore may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael D. Moore, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 151 | |
| 2 | 2015 | 97 | |
| 3 | 2014 | 38 | |
| 4 | 2018 | 38 | |
| 5 | 2011 | 25 | |
| 6 | 2000 | 15 | |
| 7 | 2007 | 14 | |
| 8 | 2007 | 14 | |
| 9 | 2017 | 14 |
About Michael D. Moore
Michael D. Moore is a scholar working on Molecular Biology, Immunology, Epidemiology, Infectious Diseases and Virology, having authored 9 papers that have together received 406 indexed citations. Recurring topics across this work include Immune cells in cancer (3 papers), Cytomegalovirus and herpesvirus research (1 paper), Neurogenesis and neuroplasticity mechanisms (1 paper), Inflammasome and immune disorders (1 paper), Antimicrobial Peptides and Activities (1 paper), Single-cell and spatial transcriptomics (1 paper), Glaucoma and retinal disorders (1 paper) and HIV Research and Treatment (1 paper). The work is most often cited by research in Immunology (145 citations), Neurology (56 citations), Business and International Management (14 citations), Aging (11 citations) and Virology (23 citations). Michael D. Moore has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include William James, Julian Buchrieser, Sally A. Cowley, Peter F. Renz, Rowan Flynn, Alexander Grundmann, Bonnie van Wilgenburg, Lee M. Jampol, Maria José Oliva-Martín and José Antonio Pérez‐Simón. Their work appears in journals such as American Journal of Ophthalmology, Cell Death and Disease, Experimental Hematology, BMC Genomics and Stem Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.